181 related articles for article (PubMed ID: 33832905)
21. Dual Activity of Hydroxypropyl-β-Cyclodextrin and Water-Soluble Carriers on the Solubility of Carvedilol.
Zoghbi A; Geng T; Wang B
AAPS PharmSciTech; 2017 Nov; 18(8):2927-2935. PubMed ID: 28432614
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
Gu F; Ning J; Fan H; Wu C; Wang Y
Acta Pharm; 2018 Jun; 68(2):145-157. PubMed ID: 29702479
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
[TBL] [Abstract][Full Text] [Related]
24. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
25. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Guo B; Zhong S; Li N; Li X; Yi J; Jin M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
[TBL] [Abstract][Full Text] [Related]
26. Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization.
Palanisamy M; Khanam J
AAPS PharmSciTech; 2011 Mar; 12(1):388-400. PubMed ID: 21359603
[TBL] [Abstract][Full Text] [Related]
27. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
28. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
29. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
30. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
[TBL] [Abstract][Full Text] [Related]
31. Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.
Ai F; Ma Y; Wang J; Li Y
Iran J Pharm Res; 2014; 13(4):1115-23. PubMed ID: 25587299
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
33. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
34. Effect of hydrophilic polymers on the solubility and dissolution enhancement of rivaroxaban/beta-cyclodextrin inclusion complexes.
Khan WH; Asghar S; Khan IU; Irfan M; Alshammari A; Riaz Rajoka MS; Munir R; Shah PA; Khalid I; Razzaq FA; Khalid SH
Heliyon; 2023 Sep; 9(9):e19658. PubMed ID: 37809727
[TBL] [Abstract][Full Text] [Related]
35. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
[TBL] [Abstract][Full Text] [Related]
36. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
Bandarkar FS; Vavia PR
Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
[TBL] [Abstract][Full Text] [Related]
37. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
38. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
39. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
40. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
